Trichomonas Rapid Testing Market, By Test Type (Molecular Rapid Tests, Immunochromatographic Tests, and Enzyme Immunoassays), By Sample Type, By End-user, By Country, and By Region Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
|
Report ID
AV4223
|
Published Date
July 2025
|
Pages
389
|
Industry
Healthcare
|
|
|
Base Year
2025
|
Historical Data
2019-2024
|
Delivery Timeline
24 Hour
|
REPORT HIGHLIGHT
Trichomonas Rapid Testing Market size was valued at US$ 469 Million in 2024, expanding at a CAGR of 5.2% from 2025 to 2032.
The Trichomonas Rapid Testing Market focuses on the development, manufacturing, and use of diagnostic tools designed for the rapid detection of Trichomonas vaginalis infections, a prevalent sexually transmitted infection. These rapid tests provide faster results compared to traditional laboratory-based methods, enabling timely diagnosis and treatment. Rising awareness of sexually transmitted infections and increased emphasis on reproductive health have significantly driven market demand. Advancements in molecular diagnostics and point-of-care testing technologies have further expanded opportunities within the market. The availability of easy-to-use, cost-effective rapid tests in clinical settings improves patient management, particularly in resource-limited environments. Additionally, the growing sexually active population and improvements in global healthcare infrastructure contribute to market growth.
Supportive regulatory frameworks and government initiatives worldwide—such as funding from the World Health Organization (WHO) and national programs in the United States, Europe, and developing countries—are accelerating the adoption of rapid diagnostic tests by promoting widespread screening and faster approvals. Public health campaigns aimed at controlling sexually transmitted infections further bolster market expansion. Overall, the market is evolving toward more sensitive, user-friendly, and portable testing solutions. Key challenges include maintaining high specificity and sensitivity to minimize false results and facing competition from alternative diagnostic methods.
Trichomonas Rapid Testing Market- Market Dynamics
The increasing prevalence of sexually transmitted infections is driving the demand for rapid diagnostic tests.
The rising incidence of sexually transmitted infections worldwide has created an urgent need for fast and reliable diagnostic tools. Traditional testing methods often involve lengthy processing times and require specialized laboratory infrastructure, leading to delays in diagnosis and treatment. Rapid testing for Trichomonas infections enables healthcare providers to identify and manage cases more efficiently, helping to reduce transmission rates.
Early detection is crucial for controlling outbreaks and improving patient outcomes. Furthermore, increasing awareness of sexual health and government-supported screening programs—such as those funded by the World Health Organization (WHO) and national health agencies in the United States, Europe, and developing countries—are driving broader adoption of these rapid tests. This demand is especially strong in low-resource settings where laboratory facilities are limited, making point-of-care rapid tests essential healthcare tools. These efforts align closely with global public health goals to curb the spread of STIs and enhance reproductive health worldwide.
Trichomonas Rapid Testing Market- Key Insights
- According to our research analyst’s analysis, the global market is projected to grow at a compound annual growth rate (CAGR) of approximately 5.2% during the forecast period from 2025 to 2032.
- In 2024, Molecular Rapid Tests are expected to hold the largest market share based on test type segmentation.
- Vaginal/Urethral Swabs were the leading sample type segment in 2024.
- Hospitals emerged as the primary end-user segment in 2024.
- Regionally, North America generated the highest revenue in 2024.
Trichomonas Rapid Testing Market- Segmentation Analysis:
The Global Trichomonas Rapid Testing Market is segmented on the basis of Test Type, Sample Type, End-user, and Region.
The Trichomonas rapid testing market is segmented by test type into Molecular Rapid Tests, Immunochromatographic Tests, and Enzyme Immunoassays, with molecular rapid tests holding the dominant position. This dominance is driven by their superior accuracy and sensitivity in detecting Trichomonas vaginalis. Molecular methods, particularly nucleic acid amplification tests (NAATs), provide reliable detection even in cases of low pathogen load, which immunoassays and chromatographic tests may fail to identify. These tests also offer rapid turnaround times and are suitable for use at or near the point of care, making them highly attractive in clinical environments. Despite their generally higher cost, the improved clinical outcomes and enhanced patient management justify their preference among healthcare providers. Furthermore, continuous technological advancements have improved the user-friendliness and accessibility of molecular rapid tests, leading to increased adoption. Many molecular platforms also support multiplex testing, allowing simultaneous detection of multiple sexually transmitted infections (STIs), further boosting their market appeal.
In terms of sample type, the market is divided into vaginal/urethral swabs and urine samples, with vaginal and urethral swabs being the most widely used. These swabs are favored in clinical settings due to their high diagnostic accuracy, especially when used with rapid antigen tests and NAATs. They are standard practice in hospitals, diagnostic laboratories, and sexual health clinics, delivering reliable results within minutes. The consistency of swab-based testing and regulatory acceptance have made it the gold standard, particularly for symptomatic female patients. Although urine samples are gaining popularity as a non-invasive alternative suitable for at-home testing, swabs continue to dominate due to their superior sensitivity and widespread clinical adoption.
On a global level, government health agencies and organizations are actively supporting improved diagnostic testing for STIs, including Trichomonas vaginalis. For example, the World Health Organization (WHO) emphasizes the importance of early and accurate diagnosis in its global STI strategy, encouraging member states to expand access to molecular diagnostic tools. Similarly, the U.S. Centers for Disease Control and Prevention (CDC) recommends NAATs as the preferred diagnostic method for Trichomonas infections and has increased funding for STI testing programs. Various national health authorities in Europe, Asia, and Latin America have also incorporated molecular rapid tests into their public health screening initiatives, reinforcing their dominant position in the market and contributing to ongoing technological adoption and development worldwide.
Trichomonas Rapid Testing Market- Competitive Landscape:
The Trichomonas rapid testing market is highly competitive, with key players emphasizing product innovation, strategic partnerships, and acquisitions to strengthen their market positions. Companies are investing heavily in research and development to improve test sensitivity, reduce turnaround times, and enhance ease of use. The growing trend toward multiplex testing platforms—capable of detecting multiple sexually transmitted infections simultaneously—is gaining significant traction.
Market participants are also expanding their geographic reach by collaborating with healthcare providers and government agencies to promote widespread screening initiatives. Pricing strategies and reimbursement policies play a critical role in shaping competition, pushing companies to balance cost-effectiveness with technological advancements. Regulatory compliance and timely product approvals remain essential competitive factors. While smaller players often target niche segments or regional markets, larger companies leverage their extensive end-user networks and strong brand recognition. Overall, the market is characterized by continuous innovation and evolving customer demands, which drive the competitive landscape.
Recent Development:
- In May 2025, Quidel Corporation announced the launch of an improved molecular rapid test for Trichomonas featuring enhanced sensitivity and faster results.
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL TRICHOMONAS RAPID TESTING MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS
- Quidel Corporation
- Hologic, Inc.
- Sekisui Diagnostics
- Abbott Laboratories
- Becton Dickinson and Company
- Thermo Fisher Scientific
- Bio-Rad Laboratories
- Meridian Bioscience, Inc.
- Siemens Healthineers
- Roche Diagnostics
- Alere Inc. (now part of Abbott)
- Cepheid
- F. Hoffmann-La Roche Ltd
- Luminex Corporation
- BioMérieux SA
- Ortho Clinical Diagnostics
- Mobidiag Oy
- GenProbe, Inc.
- Diasorin S.p.A
- Nanosphere, Inc.
GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032
- Molecular Rapid Tests
- Immunochromatographic Tests
- Enzyme Immunoassays
GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY SAMPLE TYPE- MARKET ANALYSIS, 2019 - 2032
- Vaginal/Urethral Swabs
- Urine Samples
GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032
- Hospitals
- Diagnostic Laboratories
- Clinics and Physician Offices
- Point-of-Care Testing Centers
GLOBAL TRICHOMONAS RAPID TESTING MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032
North America
- U.S.
- Canada
Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Sweden
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Indonesia
- Thailand
- Philippines
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Colombia
- Rest of LATAM
The Middle East and Africa
- Saudi Arabia
- UAE
- Israel
- Turkey
- Algeria
- Egypt
- Rest of MEA
TABLE OF CONTENT
1. Trichomonas Rapid Testing Market Overview
1.1. Study Scope
1.2. Market Estimation Years
2. Executive Summary
2.1. Market Snippet
2.1.1. Trichomonas Rapid Testing Market Snippet by Test Type
2.1.2. Trichomonas Rapid Testing Market Snippet by Sample Type
2.1.3. Trichomonas Rapid Testing Market Snippet by End-user
2.1.4. Trichomonas Rapid Testing Market Snippet by Country
2.1.5. Trichomonas Rapid Testing Market Snippet by Region
2.2. Competitive Insights
3. Trichomonas Rapid Testing Key Market Trends
3.1. Trichomonas Rapid Testing Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Trichomonas Rapid Testing Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Trichomonas Rapid Testing Market Opportunities
3.4. Trichomonas Rapid Testing Market Future Trends
4. Trichomonas Rapid Testing Industry Study
4.1. PEST Analysis
4.2. Porter’s Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. Trichomonas Rapid Testing Market: Impact of Escalating Geopolitical Tensions
5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts
6. Trichomonas Rapid Testing Market Landscape
6.1. Trichomonas Rapid Testing Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
6.2.1. Established Players’ Analysis
6.2.2. Emerging Players’ Analysis
7. Trichomonas Rapid Testing Market – By Test Type
7.1. Overview
7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
7.1.2. Molecular Rapid Tests
7.1.3. Immunochromatographic Tests
7.1.4. Enzyme Immunoassays
8. Trichomonas Rapid Testing Market – By Sample Type
8.1. Overview
8.1.1. Segment Share Analysis, By Sample Type, 2024 & 2032 (%)
8.1.2. Vaginal/Urethral Swabs
8.1.3. Urine Samples
9. Trichomonas Rapid Testing Market – By End-user
9.1. Overview
9.1.1. Segment Share Analysis, By End-user, 2024 & 2032 (%)
9.1.2. Hospitals
9.1.3. Diagnostic Laboratories
9.1.4. Clinics and Physician Offices
9.1.5. Point-of-Care Testing Centers
10. Trichomonas Rapid Testing Market– By Geography
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
10.2. North America
10.2.1. Overview
10.2.2. Trichomonas Rapid Testing Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.5. North America Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.2.6. North America Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Trichomonas Rapid Testing Key Manufacturers in Europe
10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.6. Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.8. UK
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.8.4. UK Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.8.5. UK Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.9. France
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.9.4. France Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.9.5. France Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.10. Italy
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.10.4. Italy Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.10.5. Italy Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.11. Spain
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.11.4. Spain Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.11.5. Spain Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.12. The Netherlands
10.3.12.1. Overview
10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.12.4. The Netherlands Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.12.5. The Netherlands Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.13. Sweden
10.3.13.1. Overview
10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.13.4. Sweden Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.13.5. Sweden Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.14. Russia
10.3.14.1. Overview
10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.14.4. Russia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.14.5. Russia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.15. Poland
10.3.15.1. Overview
10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.15.4. Poland Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.15.5. Poland Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.3.16. Rest of Europe
10.3.16.1. Overview
10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.3.16.4. Rest of the Europe Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.3.16.5. Rest of the Europe Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Trichomonas Rapid Testing Key Manufacturers in Asia Pacific
10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.5. APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.6. APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.7. China
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.7.4. China Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.7.5. China Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.8. India
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.8.4. India Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.8.5. India Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.11. Australia
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.11.4. Australia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.11.5. Australia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.12. Indonesia
10.4.12.1. Overview
10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.12.4. Indonesia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.12.5. Indonesia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.13. Thailand
10.4.13.1. Overview
10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.13.4. Thailand Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.13.5. Thailand Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.14. Philippines
10.4.14.1. Overview
10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.14.4. Philippines Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.14.5. Philippines Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.4.15. Rest of APAC
10.4.15.1. Overview
10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.4.15.4. Rest of APAC Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.4.15.5. Rest of APAC Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5. Latin America (LATAM)
10.5.1. Overview
10.5.2. Trichomonas Rapid Testing Key Manufacturers in Latin America
10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.5. LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.5.6. LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.10. Colombia
10.5.10.1. Overview
10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.10.4. Colombia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.5.10.5. Colombia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.5.11. Rest of LATAM
10.5.11.1. Overview
10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.5.11.4. Rest of LATAM Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.5.11.5. Rest of LATAM Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6. Middle East and Africa (MEA)
10.6.1. Overview
10.6.2. Trichomonas Rapid Testing Key Manufacturers in Middle East and Africa
10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.5. MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.6. MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.8. UAE
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.8.4. UAE Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.8.5. UAE Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.9. Israel
10.6.9.1. Overview
10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.9.4. Israel Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.9.5. Israel Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.10. Turkey
10.6.10.1. Overview
10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.10.4. Turkey Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.10.5. Turkey Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.11. Algeria
10.6.11.1. Overview
10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.11.4. Algeria Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.11.5. Algeria Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.12. Egypt
10.6.12.1. Overview
10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.12.4. Egypt Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.12.5. Egypt Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
10.6.13. Rest of MEA
10.6.13.1. Overview
10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
10.6.13.4. Rest of MEA Market Size and Forecast, By Sample Type, 2019 - 2032 (US$ Million)
10.6.13.5. Rest of MEA Market Size and Forecast, By End-user, 2019 - 2032 (US$ Million)
11. Key Vendor Analysis- Trichomonas Rapid Testing Industry
11.1. Competitive Dashboard
11.1.1. Competitive Benchmarking
11.1.2. Competitive Positioning
11.2. Company Profiles
11.2.1. Quidel Corporation
11.2.2. Hologic, Inc.
11.2.3. Sekisui Diagnostics
11.2.4. Abbott Laboratories
11.2.5. Becton Dickinson and Company
11.2.6. Thermo Fisher Scientific
11.2.7. Bio-Rad Laboratories
11.2.8. Meridian Bioscience, Inc.
11.2.9. Siemens Healthineers
11.2.10. Roche Diagnostics
11.2.11. Alere Inc. (now part of Abbott)
11.2.12. Cepheid
11.2.13. F. Hoffmann-La Roche Ltd
11.2.14. Luminex Corporation
11.2.15. BioMérieux SA
11.2.16. Ortho Clinical Diagnostics
11.2.17. Mobidiag Oy
11.2.18. GenProbe, Inc.
11.2.19. Diasorin S.p.A
11.2.20. Nanosphere, Inc.
12. 360 Degree AnalystView
13. Appendix
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
Related Reports
Credibility and Certifications
Trusted Insights, Certified Excellence! Coherent Market Insights is a certified data advisory and business consulting firm recognized by global institutes.
ISO 9001:2015
ESOMAR Corporate
GDPR Compliance
D-U-N-S Registered
BBB Accreditation
MRS
